The PM Society is delighted to announce a new partnership with the CIM to build capability and excellence in marketing in the pharmaceutical industry.
Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.
Top FDA officials have spelled out their strategic priorities in the coming years, including the use of AI to "increase efficiency."
Pharma wants to use AI for digital engagement with healthcare professionals and patients, but most feel unprepared to forge ahead, says survey.
In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.
Editor's Picks
